Table 1.
Cases of bacteremia × control cases (non-bacteremia).
| Characteristics |
Cases of bacteremia with Acinetobacter |
Control cases (non-bacteremic) |
p |
|---|---|---|---|
| (n = 35) | (n = 70) | ||
| Demographic parameters | |||
| Age, months, median (IQR) | 7 (1–172) | 4.5 (1–169) | 0.95 |
| Male gender, n (%) | 21 (60) | 34 (48.6) | 0.26 |
| Concomitant illness, n (%) | |||
| Prematurity | 10 (28.6) | 21 (30) | 0.88 |
| Neurometabolic diseases | 10 (28.6) | 6 (8.6) | <0.01 |
| Hematologic malignancy | 4 (11.4) | 2 (2.9) | 0.09 |
| Congenital cardiac disease | 3 (8.6) | 11 (15.7) | 1 |
| Chronic lung disease | 2 (5.7) | 4 (5.7) | 1.00 |
| Renal insufficiency | 2 (5.7) | 4 (5.7) | 1.00 |
| Immunosuppressive status | 4 (11.4) | 9 (12.9) | 1.00 |
| Neutropenia | 5 (14.3) | 6 (8.6) | 0.50 |
| Duration (days), median (IQR) | |||
| Of hospitalization | 24 (6–359) | 16 (3–169) | 0.01 |
| From hospitalization to bacteremia | 13 (4–288) | 11 (3–282) | 0.62 |
| Invasive procedures, n (%) | |||
| Urinary catheter | 3 (8.6) | 5 (7.1) | 1.00 |
| Central venous catheter | 6 (17.1) | 2 (2.9) | 0.01 |
| Nasogastric tube | 19 (54.3) | 23 (32.9) | 0.03 |
| Mechanical ventilation | 14 (40) | 21 (3.0) | 0.30 |
| Thoracic drainage | 2 (5.7) | 2 (2.9) | 0.59 |
| Peritoneal dialysis | 1 (2.9) | 1 (1.4) | 1.00 |
| Major surgery | 3 (8.6) | 1 (1.4) | 0.10 |
| Prolonged antibacterial use >10 days, n (%) | 18 (51.4) | 50 (71.4) | 0.05 |
| Prolonged hospital stay >20 days, n (%) | 24 (68.6) | 30 (42.9) | 0.01 |
| Mortality rates, n (%) | 11 (31.4) | 20 (28.6) | 0.76 |